![Alexia Perouse](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Alexia Perouse
Direttore/Membro del Consiglio presso
SPINEGUARD
Profilo
Alexia Perouse is the founder of iBionext SAS, which was founded in 2015.
She is currently the Chairman of Cyann Holding, Chairman of T-Heart SAS, Independent Director of SpineGuard SA, and Director of Chronolife SAS. In the past, she served as a Director of CircuLite, Inc., Stentys SA, EOS Imaging SA, Cellnovo Group SA, Eye Tech Care SA, ULURU Delaware, Inc., Amakem NV, Pixium Vision SA, Tissium SA, Brainever SAS, Tilak Healthcare SAS, Observer of Enterome SA, and as a Partner of Omnes Capital SAS from 2005 to 2015.
She was also a Member-Supervisory Board of Mutabilis SA and SuperSonic Imagine SA.
Posizioni attive di Alexia Perouse
| Società | Posizione | Inizio |
|---|---|---|
| SPINEGUARD | Direttore/Membro del Consiglio | 27/03/2009 |
Chronolife SAS
 Chronolife SAS Miscellaneous Commercial ServicesCommercial Services Provides research and development on natural sciences | Direttore/Membro del Consiglio | - |
Cyann Holding
 Cyann Holding Financial ConglomeratesFinance Function as an investment holding company | Presidente | - |
iBionext SAS
 iBionext SAS Investment ManagersFinance iBionext is an active manager invests in young companies located in France. The firm targets companies operating in the health technology (biotech/medtech/e-health). They provide equity financing for seed, later and growth capital requirements. | Amministratore Delegato | 01/01/2015 |
T-Heart SAS
 T-Heart SAS Miscellaneous Commercial ServicesCommercial Services Provides research and development services on natural sciences | Presidente | 08/12/2018 |
Precedenti posizioni note di Alexia Perouse
| Società | Posizione | Fine |
|---|---|---|
Omnes Capital SAS /Venture/
 Omnes Capital SAS /Venture/ Investment ManagersFinance Omnes-Venture is an active manager which aims to combine an industrial and strategic overview of their target sectors with operational support for investee companies and financial optimization of investments. The firm takes minority stakes in recently founded businesses with strong European and international potential, focusing on the electronics, software, telecoms, life sciences and web technology services sectors. Their investment policy draws on exclusive sources of deal flow, including the management team's personal networks and privileged links to incubator funds, start-up funds, research labs, fundraisers and Crdit Agricole group's proprietary networks. They typically invest between 2 and 10 million euros. Omnes-Venture partners with investee companies, taking seats on supervisory boards or the board of directors, while respecting investee management's independence. They contribute to the company's strategy and development opportunities, select candidates for key positions in investee companies, working to optimize their financial resources and source industrial and financial partnerships. | Director of Investments | 31/12/2015 |
| CELLNOVO | Direttore/Membro del Consiglio | 11/09/2015 |
| STENTYS | Direttore/Membro del Consiglio | 27/05/2014 |
| EOS IMAGING | Direttore/Membro del Consiglio | - |
| ░░░ ░░░░ ░░░░ ░░ | ░░░░░░░░░░░░░░░░ ░░░ ░░░░░░░░░ | - |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
34
Relazioni di 1° grado
20
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 20 |
|---|---|
CircuLite, Inc.
 CircuLite, Inc. Medical DistributorsDistribution Services Provides treatment for heart disorders | Distribution Services |
Mutabilis SA
 Mutabilis SA Pharmaceuticals: MajorHealth Technology Develops antibiotics and antibacterial therapies | Health Technology |
SuperSonic Imagine SA
 SuperSonic Imagine SA Medical SpecialtiesHealth Technology Develops and manufactures ultrasound systems & medical imaging devices | Health Technology |
Omnes Capital SAS /Venture/
Omnes Capital SAS /Venture/ Investment ManagersFinance Omnes-Venture is an active manager which aims to combine an industrial and strategic overview of their target sectors with operational support for investee companies and financial optimization of investments. The firm takes minority stakes in recently founded businesses with strong European and international potential, focusing on the electronics, software, telecoms, life sciences and web technology services sectors. Their investment policy draws on exclusive sources of deal flow, including the management team's personal networks and privileged links to incubator funds, start-up funds, research labs, fundraisers and Crdit Agricole group's proprietary networks. They typically invest between 2 and 10 million euros. Omnes-Venture partners with investee companies, taking seats on supervisory boards or the board of directors, while respecting investee management's independence. They contribute to the company's strategy and development opportunities, select candidates for key positions in investee companies, working to optimize their financial resources and source industrial and financial partnerships. | Finance |
Stentys SA
 Stentys SA Medical SpecialtiesHealth Technology Engages in development and production of coronary stents | Health Technology |
EOS Imaging SA
 EOS Imaging SA Medical SpecialtiesHealth Technology Designs imaging systems and orthopedic solutions | Health Technology |
Cellnovo Group SA
 Cellnovo Group SA Medical SpecialtiesHealth Technology Manufactures medical device that manages diabetic control | Health Technology |
Eye Tech Care SA
 Eye Tech Care SA Medical SpecialtiesHealth Technology Develops medical devices for non-invasive eye disease treatment | Health Technology |
SpineGuard SA
 SpineGuard SA Medical SpecialtiesHealth Technology Designs and manufactures medical devices | Health Technology |
Enterome SA
 Enterome SA Pharmaceuticals: MajorHealth Technology Develops immunomodulatory drugs for treatment of cancer | Health Technology |
ULURU Delaware, Inc.
 ULURU Delaware, Inc. BiotechnologyHealth Technology Develops drug delivery systems | Health Technology |
Amakem NV
 Amakem NV Medical/Nursing ServicesHealth Services Operates as a clinical stage ophthalmology company that provides treatments for serious eye conditions | Health Services |
Pixium Vision SA
 Pixium Vision SA Medical SpecialtiesHealth Technology Operates as a bioelectronics company that develops bionic vision systems | Health Technology |
Tissium SA
 Tissium SA BiotechnologyHealth Technology Develops biomorphic and programmable polymers for tissue reconstruction | Health Technology |
iBionext SAS
iBionext SAS Investment ManagersFinance iBionext is an active manager invests in young companies located in France. The firm targets companies operating in the health technology (biotech/medtech/e-health). They provide equity financing for seed, later and growth capital requirements. | Finance |
Brainever SAS
 Brainever SAS Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops novel therapies for patients | Health Technology |
Chronolife SAS
Chronolife SAS Miscellaneous Commercial ServicesCommercial Services Provides research and development on natural sciences | Commercial Services |
Tilak Healthcare SAS
 Tilak Healthcare SAS Packaged SoftwareTechnology Services Offers medical mobile application for monitoring the visual parameters of patients | Technology Services |
Cyann Holding
Cyann Holding Financial ConglomeratesFinance Function as an investment holding company | Finance |
T-Heart SAS
T-Heart SAS Miscellaneous Commercial ServicesCommercial Services Provides research and development services on natural sciences | Commercial Services |
